Forte Biosciences, Inc. (FBRX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Forte Biosciences, Inc. (FBRX) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

FBRX Income Statement

Forte Biosciences, Inc. (FBRX) annual income statement — 11-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	19K	-45K	17K	15K	13K	10K	10K	10K	9K	6K	3K	0	0	0	0	0	0	0	9K
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-19K	45K	-17K	-15K	-13K	-10K	-10K	-10K	-9K	-6K	-3K	0	0	0	0	0	0	0	-9K
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	100%	-46.15%	550%	-70%	-50%	-44.44%	-66.67%	-233.33%	-	-	-	-	-	-	-	100%	100%	100%	-	-
Operating Expenses	24.6M	22.44M	24.62M	18.37M	11.56M	16.11M	7.34M	8.62M	12.81M	7.79M	6.38M	10.21M	9.03M	6.86M	4.94M	3.42M	3.02M	2.51M	3.3M	7.69M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	2.27M	1.97M	2.83M	3.18M	2.96M	3.43M	2.11M	2.76M	7.08M	3.44M	2.81M	3.85M	1.9M	2.07M	2.45M	2.04M	1.99M	1.82M	1.95M	2.04M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	150K	20.32M	21.44M	15.05M	8.62M	12.54M	5.23M	5.72M	5.74M	4.35M	3.57M	6.37M	7.14M	4.79M	2.49M	1.38M	1.03M	693K	1.35M	5.65M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	1000K	150K	345K	150K	0	150K	0	150K	0	0	0	0	0	0	0	0	-15K	0	0	0
Operating Income	-24.6M	-22.44M	-24.57M	-18.38M	-11.58M	-16.12M	-7.35M	-8.63M	-12.82M	-7.8M	-6.38M	-10.22M	-9.03M	-6.86M	-4.94M	-3.42M	-3.02M	-2.51M	-3.3M	-7.7M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-112.48%	-39.17%	-234.25%	-113.04%	9.67%	-106.61%	-15.2%	15.53%	-41.89%	-13.84%	-29.2%	-198.45%	-199.14%	-172.67%	-49.71%	55.54%	47.45%	46.97%	26.57%	-53.73%
EBITDA	-23.14M	-22.42M	-24.55M	-18.37M	-11.56M	-16.11M	-7.34M	-8.62M	-12.81M	-7.79M	-6.38M	-10.21M	0	-6.75M	-4.93M	-3.4M	-3.01M	-2.57M	-3.34M	-7.69M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-100.09%	-39.16%	-234.45%	-113.09%	9.71%	-106.68%	-15.15%	15.61%	-	-15.43%	-29.31%	-200.38%	100%	-163.07%	-47.56%	55.79%	47.49%	45.69%	25.41%	-53.95%
D&A (Non-Cash Add-back)	0	19K	19K	17K	15K	13K	10K	10K	10K	9K	6K	3K	9.03M	0	9K	0	9K	0	0	9K
EBIT	-23.14M	-21.76M	-23.75M	-17.68M	-11.25M	-15.66M	-7.16M	-8.39M	-12.51M	-7.42M	-7M	-10.22M	-9.03M	-6.75M	-4.94M	-3.4M	-3.02M	-2.57M	-3.34M	-7.75M
Net Interest Income	0	0	0	0	0	0	1.31M	0	0	0	1.02M	0	0	0	-6K	0	-15K	-53K	-42K	0
Interest Income	0	0	0	0	0	0	1.31M	0	0	0	1.12M	0	0	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	102K	0	0	0	6K	0	15K	53K	42K	0
Other Income/Expense	1.47M	676K	820K	701K	330K	468K	196K	237K	307K	384K	509K	261K	138K	102K	62K	23K	-15K	-53K	-42K	-52K
Pretax Income	-23.14M	-21.76M	-23.75M	-17.68M	-11.25M	-15.66M	-7.16M	-8.39M	-12.51M	-7.42M	-5.87M	-9.96M	-8.9M	-6.75M	-4.88M	-3.4M	-3.04M	-2.57M	-3.34M	-7.75M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	193K	373K	1.04M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	-0.83%	-1.71%	-4.37%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-23.33M	-22.14M	-24.79M	-17.68M	-11.25M	-15.66M	-7.16M	-8.39M	-12.51M	-7.42M	-5.87M	-9.96M	-8.9M	-6.75M	-4.88M	-3.4M	-3.05M	-2.57M	-3.34M	-7.75M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-107.41%	-41.39%	-246.44%	-110.7%	10.09%	-111%	-21.85%	15.7%	-40.64%	-9.88%	-20.25%	-192.79%	-191.67%	-163.07%	-46.15%	56.13%	47.52%	46.57%	26.99%	-51.98%
Net Income (Continuing)	-23.33M	-22.14M	-24.79M	-17.68M	-11.25M	-15.66M	-7.16M	-8.39M	-12.51M	-7.42M	-5.87M	-9.96M	-8.9M	-6.75M	-4.88M	-3.4M	-3.04M	-2.57M	-3.34M	-7.75M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.97	-1.24	-1.39	-0.99	-0.96	-1.37	-1.12	-4.54	-6.78	-4.77	-4.04	-6.57	-10.57	-8.04	-5.81	-4.49	-5.14	-4.35	-5.66	-13.61
EPS Growth %	-1.04%	9.49%	-24.11%	78.19%	85.84%	71.28%	72.28%	30.93%	35.84%	40.65%	30.41%	-46.37%	-105.58%	-84.84%	-2.56%	67%	51.88%	52.02%	36.51%	41.25%
EPS (Basic)	-0.97	-1.24	-1.39	-0.99	-0.96	-1.37	-1.12	-4.54	-6.78	-4.77	-4.04	-6.57	-10.57	-8.04	-5.81	-4.49	-5.14	-4.35	-5.66	-13.61
Diluted Shares Outstanding	23.79M	17.84M	17.86M	17.79M	11.74M	11.4M	6.39M	1.85M	1.85M	1.55M	1.45M	1.51M	841.87K	840.27K	840K	757.1K	590.45K	590.39K	590.18K	569.65K
Basic Shares Outstanding	23.79M	17.84M	17.86M	17.79M	11.74M	11.4M	6.39M	1.85M	1.85M	1.55M	1.45M	1.51M	841.87K	840.27K	840K	757.1K	590.45K	590.39K	590.18K	569.65K
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-